Richard Newitter
Stock Analyst at Truist Securities
(3.94)
# 605
Out of 5,150 analysts
455
Total ratings
50%
Success rate
10.48%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Maintains: Buy | $47 → $30 | $26.93 | +11.40% | 17 | Mar 2, 2026 | |
| KIDS OrthoPediatrics | Maintains: Hold | $19 → $20 | $18.48 | +8.23% | 11 | Mar 2, 2026 | |
| LNTH Lantheus Holdings | Maintains: Buy | $82 → $89 | $77.50 | +14.84% | 23 | Mar 2, 2026 | |
| SIBN SI-BONE | Reiterates: Buy | $23 → $24 | $14.69 | +63.38% | 2 | Feb 24, 2026 | |
| IRTC iRhythm Holdings | Reiterates: Buy | $215 → $200 | $127.95 | +56.31% | 20 | Feb 23, 2026 | |
| TNDM Tandem Diabetes Care | Reiterates: Hold | $24 → $27 | $23.23 | +16.23% | 5 | Feb 23, 2026 | |
| ITGR Integer Holdings | Maintains: Buy | $95 → $97 | $86.06 | +12.71% | 13 | Feb 20, 2026 | |
| PODD Insulet | Maintains: Buy | $390 → $360 | $242.89 | +48.22% | 5 | Feb 19, 2026 | |
| DXCM DexCom | Reiterates: Buy | $82 → $80 | $72.74 | +9.98% | 4 | Feb 17, 2026 | |
| INSP Inspire Medical Systems | Maintains: Hold | $96 → $70 | $64.32 | +8.83% | 31 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $92 → $89 | $84.80 | +4.95% | 23 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $95 | $71.89 | +32.15% | 21 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $25 | $11.36 | +120.07% | 6 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $370 → $374 | $338.57 | +10.46% | 8 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $34.96 | +28.72% | 6 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $4 → $3 | $1.45 | +106.90% | 19 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $400 → $392 | $381.89 | +2.65% | 25 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $110 → $107 | $96.04 | +11.42% | 19 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $620 → $650 | $498.00 | +30.52% | 32 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $145 | $115.00 | +26.09% | 7 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $93 → $105 | $90.46 | +16.07% | 30 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 → $20 | $12.99 | +53.96% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $13 → $15 | $10.40 | +44.23% | 19 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $137 | $119.18 | +14.95% | 38 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $95.75 | +18.02% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $7.71 | +159.40% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $83.07 | -1.29% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $171.06 | +46.15% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $2.90 | +796.55% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $182.16 | +322.71% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $75.67 | +12.33% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $12.19 | +64.07% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $29.05 | -7.06% | 5 | Feb 23, 2021 |
PROCEPT BioRobotics
Mar 2, 2026
Maintains: Buy
Price Target: $47 → $30
Current: $26.93
Upside: +11.40%
OrthoPediatrics
Mar 2, 2026
Maintains: Hold
Price Target: $19 → $20
Current: $18.48
Upside: +8.23%
Lantheus Holdings
Mar 2, 2026
Maintains: Buy
Price Target: $82 → $89
Current: $77.50
Upside: +14.84%
SI-BONE
Feb 24, 2026
Reiterates: Buy
Price Target: $23 → $24
Current: $14.69
Upside: +63.38%
iRhythm Holdings
Feb 23, 2026
Reiterates: Buy
Price Target: $215 → $200
Current: $127.95
Upside: +56.31%
Tandem Diabetes Care
Feb 23, 2026
Reiterates: Hold
Price Target: $24 → $27
Current: $23.23
Upside: +16.23%
Integer Holdings
Feb 20, 2026
Maintains: Buy
Price Target: $95 → $97
Current: $86.06
Upside: +12.71%
Insulet
Feb 19, 2026
Maintains: Buy
Price Target: $390 → $360
Current: $242.89
Upside: +48.22%
DexCom
Feb 17, 2026
Reiterates: Buy
Price Target: $82 → $80
Current: $72.74
Upside: +9.98%
Inspire Medical Systems
Feb 12, 2026
Maintains: Hold
Price Target: $96 → $70
Current: $64.32
Upside: +8.83%
Feb 11, 2026
Maintains: Hold
Price Target: $92 → $89
Current: $84.80
Upside: +4.95%
Feb 5, 2026
Maintains: Buy
Price Target: $120 → $95
Current: $71.89
Upside: +32.15%
Feb 2, 2026
Maintains: Buy
Price Target: $37 → $25
Current: $11.36
Upside: +120.07%
Jan 16, 2026
Downgrades: Hold
Price Target: $370 → $374
Current: $338.57
Upside: +10.46%
Dec 18, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $34.96
Upside: +28.72%
Dec 18, 2025
Maintains: Hold
Price Target: $4 → $3
Current: $1.45
Upside: +106.90%
Dec 18, 2025
Maintains: Hold
Price Target: $400 → $392
Current: $381.89
Upside: +2.65%
Dec 18, 2025
Maintains: Hold
Price Target: $110 → $107
Current: $96.04
Upside: +11.42%
Dec 18, 2025
Maintains: Buy
Price Target: $620 → $650
Current: $498.00
Upside: +30.52%
Dec 18, 2025
Maintains: Buy
Price Target: $120 → $145
Current: $115.00
Upside: +26.09%
Nov 18, 2025
Reiterates: Buy
Price Target: $93 → $105
Current: $90.46
Upside: +16.07%
Nov 7, 2025
Reiterates: Buy
Price Target: $18 → $20
Current: $12.99
Upside: +53.96%
Oct 15, 2025
Maintains: Hold
Price Target: $13 → $15
Current: $10.40
Upside: +44.23%
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $119.18
Upside: +14.95%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $95.75
Upside: +18.02%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $7.71
Upside: +159.40%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $83.07
Upside: -1.29%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $171.06
Upside: +46.15%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $2.90
Upside: +796.55%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $182.16
Upside: +322.71%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $75.67
Upside: +12.33%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $12.19
Upside: +64.07%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $29.05
Upside: -7.06%